This page uses content from Wikipedia and is licensed under CC BY-SA.
|AHFS/Drugs.com||International Drug Names|
|Chemical and physical data|
|Molar mass||209.31 g/mol|
|3D model (JSmol)|
|‹See TfM› (what is this?)|
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe.
The main side effects are drowsiness, dizziness, hallucinations and minor gastrointestinal complaints. In 2008 the Japanese Ministry of Health, Labour, and Welfare mandated that Boehringer add a warning to the label concerning the risk of sudden onset of sleep.:15
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|